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The amyloid b-protein (Ab) is the main component of Alzheimer’s disease-related senile plaques. Although Ab
is associated with the development of Alzheimer’s disease, it has not been shown which forms of Ab induce
neurodegeneration in vivo and which types of neurons are vulnerable. To address these questions, we implanted
DiI crystals into the left frontocentral cortex of APP23 transgenic mice overexpressing mutant human APP
(amyloid precursor protein gene) and of littermate controls. Traced commissural neurons in layer III of the
right frontocentral cortex were quantified in 3-, 5-, 11- and 15-month-old mice. Three different types of
commissural neurons were traced. At 3 months of age no differences in the number of labelled commissural
neurons were seen in APP23 mice compared with wild-type mice. A selective reduction of the heavily ramified
type of neurons was observed in APP23 mice compared with wild-type animals at 5, 11 and 15 months of age,
starting when the first Ab-deposits occurred in the frontocentral cortex at 5 months. The other two types of
commissural neurons did not show alterations at 5 and 11months. At 15months, the number of traced sparsely
ramified pyramidal neurons was reduced in addition to that of the heavily ramified neurons in APP23 mice
compared with wild-type mice. At this time Ab-deposits were seen in the neo- and allocortex as well as in the
basal ganglia and the thalamus. In summary, our results show that Ab induces progressive degeneration of
distinct types of commissural neurons. Degeneration of the most vulnerable neurons starts in parallel with the
occurrence of the first fibrillar Ab-deposits in the neocortex, that is, with the detection of aggregated Ab. The
involvement of additional neuronal subpopulations is associated with the expansion of Ab-deposition into
further brain regions. The vulnerability of different types of neurons to Ab, thereby, is presumably related
to the complexity of their dendritic morphology.
Keywords: Alzheimer’s disease pathology; animal models; beta-amyloid; neurodegenerative mechanisms;
selective vulnerability
Abbreviations: Ab = amyloid b protein; APP = amyloid precursor protein; BDA = biotinylated dextran amine;
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Introduction
Alzheimer’s disease is histopathologically characterized by
amyloid b-protein (Ab) deposits and neurofibrillary tangles
(NFTs) (Masters et al., 1985; Braak and Braak, 1991; Dickson,
1997; Esiri et al., 1997). Ab is derived from the amyloid
precursor protein (APP) (Kang et al., 1987). Mutations in
the APP gene are linked to early onset familial Alzheimer’s
disease (Tanzi et al., 1987; Bertram and Tanzi, 2003). Trans-
genic mice overexpressing human APP harbouring these
mutations are used as models for studying Alzheimer’s
disease-related Ab-deposition. Ab-deposits in humans as
well as in transgenic mouse models appear predominantly
in the neocortex and hippocampus (Alzheimer, 1907; Braak
and Braak, 1991; Arriagada et al., 1992; Games et al., 1995;
Hsiao et al., 1996; Sturchler-Pierrat et al., 1997) and expand
in a similar hierarchical sequence throughout the brain (Thal
et al., 2002b; Wiederhold et al., 2004; Thal et al., 2006).
Although synaptic changes represent an important feature
of Alzheimer’s disease pathology (DeKosky and Scheff,
1990; Masliah et al., 1994) and Ab-toxicity (Lacor et al.,
2004; Tsai et al., 2004), it is not clear whether increasing
levels of Ab as represented by the hierarchical deposition
of Ab in different brain regions support the progression of
neurodegeneration.
In APP-transgenic mouse models there is only minor neu-
ronal loss (Calhoun et al., 1998; Schmitz et al., 2004) and no
tangle formation (Games et al., 1995; Masliah et al., 1996;
Sturchler-Pierrat et al., 1997). Recently, Wu et al. (2004)
described dendritic alterations in superficial granule cells
of the dorsal blade of the dentate gyrus in young PDAPP
mice. However, it is not clear whether such alterations of the
dendritic tree lead to changes in neuronal connectivity.
In the human brain, pyramidal cells of the layers III and V
are vulnerable to Alzheimer’s disease (Alzheimer, 1907; Terry
et al., 1981; Braak and Braak, 1991; Duyckaerts and Dickson,
2003). Axonal loss in the corpus callosum seen in the early
stages (Hampel et al., 1998; Weis et al., 1991; Yamauchi et al.,
1993) indicates that commissural neurons in these layers
display an early target of Alzheimer’s disease-related neuro-
degeneration. Furthermore, the number of neurons in layers
III and V in the frontal neocortex is reduced in Down
syndrome cases (Davidoff, 1928). Therefore, commissural
neurons of layer III of the frontal neocortex from APP-
transgenic mice represent a suitable model for studying
Ab-induced changes in neuronal connectivity.
To measure the progression of Ab-induced neurodegen-
eration in commissural neurons in APP transgenic mice, we
examined the degree of neuronal connectivity in layer III of
the frontocentral neocortex at 3, 5, 11 and 15 months of age.
To determine the degree of neuronal connectivity, retrograde
tracing—a sensitive method to measure the number of neu-
rons being connected to the tracer application site—was used.
A decrease in the number of traced neurons would mean a
loss of connectivity caused by several reasons such as neu-
ronal death, axonal injury or decrease of collaterals sent from
a given type of neurons.
Using this tracing method we showed that degeneration of
neuronal connectivity starts in parallel with the occurrence of
fibrillar Ab-deposits, that is, aggregated Ab, in the neocortex
of 5-month-old APP23 mice and is restricted to a distinct
type of neurons. Expansion of Ab-deposition into further
brain regions and the increasing Ab-levels lead to the invol-
vement of a second type of commissural neurons.
Material and methods
Animals
APP23 mice were generated as described previously (Sturchler-
Pierrat et al., 1997) and continuously back-crossed to C57BL/6.
An expression construct containing a murine Thy-1 promoter
was used to drive neuron-specific expression of human mutant
APP751 with the Swedish double mutation 670/671 KM!NL.
Heterozygous female APP23 mice were analysed at 3 months of
age (n = 12), 5 months of age (n = 16), 11 months of age (n = 13)
and 15 months of age (n = 15). As control, female wild-type litter-
mates were analysed at 3 months of age (n = 8), 5 months of age
(n = 13), 11 months of age (n = 14) and 15 months of age (n = 9).
Brain homogenates, immunoprecipitation,
western blot analysis and enzyme-linked
immunosorbent assay (ELISA)
Forebrain hemispheres (excluding olfactory bulb, cerebellum and
brainstem) were weighed and homogenized by sonication in
10 vol. of buffer [20 mM Tris–HCl (pH 7.6), 137 mM sodium
chloride, protease inhibitor cocktail (Complete, Roche Molecular
Biochemical, Mannheim, Germany)]. For immunoprecipitation,
homogenates were supplemented with 1% sodium dodecyl sulphate,
heated to 95C for 3 min, diluted with 9 vol. of homogenization
buffer and cleared by centrifugation at 15C for 15 min at 20 000· g.
Ab-peptides were immunoprecipitated using the monoclonal anti-
body b1 reacting with the amino-terminus of Ab (Schrader-Fischer
and Paganetti, 1996) and protein G-coated magnetic beads (Dynal
Biotech, Hamburg, Germany). Precipitates or whole homogenates
were separated on 10% Tris–bicine gels with 8 M urea as described
(Klafki et al., 1996; Staufenbiel and Paganetti, 1999). In this system,
Ab1–40 migrates slower than Ab1–42. Proteins were transferred to
Immobilon-P membranes (Millipore, Carrigtwohill, Ireland). Ab-
peptides were fixed to the membrane by heating it to 95C for 3 min
in phosphate-buffered saline (PBS; Sigma, Taufkirchen, Germany)
(Staufenbiel and Paganetti, 1999). Full-length APP (flAPP) was
detected with rabbit antiserum APP-C8 raised against the carboxy-
terminal amino acids of APP (Schrader-Fischer and Paganetti,
1996), which are identical in mice and humans. Transgene-derived
APP and Ab were detected with the monoclonal antibody 6E10
(Signet, MA, USA). After incubation of the blots with the appro-
priate peroxidase coupled secondary antibodies (Jackson Immuno-
research, Soham, UK and Sigma, Taufkirchen, Germany), proteins
were detected by visualizing chemiluminescence (ECL advance,
Amersham Pharmacia Biotech, NJ, USA) on autoradiographic
films (Hyperfilm ECL, Amersham Pharmacia Biotech).
For analysis of Ab by ELISA, forebrain homogenates from APP23
mice of each age group (3 months: n = 6; 5 months: n = 6; 11 months:
n = 4; 15 months: n = 7) were supplemented with concentrated
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formic acid to a final concentration of 70%. After 15 min of incuba-
tion on ice and mixing every 5 min, the samples were neutralized by
addition of 19 vol. 1 M Tris base supplemented with protease inhi-
bitor cocktail. The extracts were cleared by centrifugation (20 000· g
for 15 min at 4C). Supernatants from young (3 or 5 months) APP23
mice were directly loaded on sandwich ELISA plates for quantifica-
tion of Ab-peptides (Ab1–40: ELISA from IBL, Hamburg, Germany;
Ab1–42: ELISA from Innogenetics, Ghent, Belgium). Supernatants
from 11- and 15-month-old APP23 mice were diluted as necessary in
dilution buffers supplied with the ELISAs. Standard curves were
prepared with synthetic peptides Ab1–40 and Ab1–42 purchased
from Bachem (Bubendorf, Switzerland) and diluted in extracts of
non-transgenic mouse forebrain prepared in parallel as described
above. Each sample was analysed in duplicate.
Tissue preparation and DiI tracing
For DiI tracing brains of 3-, 5-, 11- and 15-month-old APP23
(3 months: n = 6; 5 months: n = 9; 11 months: n = 8; 15 months:
n = 8) and wild-type mice (3 months: n = 6; 5 months: n = 12;
11 months: n = 13; 15 months: n = 9) were studied. Animals were
treated in agreement with the German law on the use of laboratory
animals. Mice were anaesthetized. Perfusion was performed trans-
cardially with Tris-buffered saline (TBS) with heparin (pH 7.4)
followed by the injection of 0.1 M PBS (pH 7.4) containing 2.6%
paraformaldehyde (PFA), 0.8% iodoacetic acid, 0.8% sodium per-
iodate and 0.1 M D-L lysine. The brains were removed in total and
post-fixed in 2.6% phosphate-buffered PFA (pH 7.4) containing
0.8% iodoacetic acid, 0.8% sodium periodate and 0.1 M D-L lysine
(Galuske et al., 2000). Three days later a single crystal (0.3 mm3) of
the carbocyanine dye DiI (Molecular Probes, Eugene, OR, USA) was
implanted into the left frontocentral cortex, 1 mm rostrally from the
central sulcus, 2 mm laterally from the middle line and 1 mm deep in
the cortex (Fig. 1A). This dye allows precise Golgi-like tracing of
neurons in post-mortem fixed tissue in a quality similar to in vivo
tracing methods using rhodamine tracers even in only weakly traced
neurons (Galuske and Singer, 1996). After incubation in 2.6%
phosphate-buffered PFA for at least 3 months at 37C, 100-mm-
thick coronal vibratome sections were cut. Sections were mounted in
TBS for microscopic analysis.
In vivo tracing with biotinylated dextrane
amine (BDA)
For in vivo tracing with BDA (Molecular Probes), three 3-month-old
C57BL/6 wild-type mice were anaesthetized with ketamine/Rompun
and placed in a stereotactic frame. After incision of the skin, a fine
hole was drilled into the skull 0.1 mm caudal and 0.2 mm lateral to
bregma. A finely drawn glass capillary was stereotactically placed
into the frontal cortex (approximal depth = 0.5 mm), and 1 ml BDA
was slowly injected over a 3-min period. After withdrawal of the
capillary, the skin wound was closed by suture, and animals were
allowed to survive for 3 days. For tissue sampling, animals were
anaesthetized, perfused transcardially with 4% PFA and dissected.
Brain slices were embedded in gloop, a mixture of egg albumin,
gelatine, sucrose and glutaraldehyde, and 50-mm vibratome sections
were cut. BDA was visualized using an avidin–peroxidase-based
method (Vectastain, Vector Laboratories, Burlingame, CA, USA)
with 3,3-diaminobenzidine (DAB) as chromogen. Sections were
dehydrated and coverslipped.
Microscopic and quantitative analysis
In layer III of the frontocentral cortex of the right hemisphere,
contralateral to the implantation site of the tracer, the morphology
of traced commissural neurons was examined. The traced neurons
were assigned to different types according to their morphology.
Then the number of traced commissural neurons of each type in
wild-type mice was compared with that in APP23 mice. For quali-
tative and quantitative analysis 10 consecutive sections (100-mm
Fig. 1 Application site of the DiI tracer in the mouse brain and region of interest for the analysis of traced commissural neurons. (A) The DiI
tracer was implanted into the left frontocentral cortex: 1 mm rostrally from the central sulcus, 2 mm laterally from the median sagittal plane
and 1 mm deep in the cortex (arrow). In so doing, the tracer was placed into layers I–V of the frontocentral cortex. (B) The schematic
representation shows a coronal section of the mouse brain at the level of the tracer application site. Layer III commissural neurons within
the contralateral frontocentral cortex labelled by the DiI tracer were studied in the secondary and primary motor cortex (M1 and M2)
and the somatosensory cortex (S1) (area marked in red) as determined by the following coordinates: the medial boundary was established
as the vertical (red) line that separates the cingulate cortex (Cg) from the secondary motor cortex (M2). The horizontal limit was referred
to as the horizontal (blue) line that separated the primary somatosensory cortex (S1) from the insular cortex (I).
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thickness each) representing a tissue block of 1 mm thickness were
studied for each mouse. Analysis started at the anterior commissure
setting the caudal limit of the investigated tissue block. For each
coronal section, the medial boundary of the region investigated was
set as the vertical line at the cingulum that separated the cingulate
cortex (Cg) from secondary motor cortex (M2) (Fig. 1B). The hor-
izontal boundary was set as the horizontal line separating the pri-
mary somatosensory cortex (S1) from the insular cortex (I) (Fig. 1B).
For the qualitative analysis a laser scanning confocal microscope
(Leica TCS NT, Leica, Bensheim, Germany) was used. Stacks of 2D
images were superimposed digitally using the Image J Image Pro-
cessing and Analysis software (NIH, Bethesda, MD, USA), and 3D
data sets were generated for the visualization of neurons with their
entire dendritic tree.
For quantification of the commissural neurons in APP-transgenic
and wild-type mice, traced neurons in layer III were counted in the
region of interest depicted in Fig. 1 in 10 consecutive sections of the
tissue block taken for qualitative and quantitative analysis using a
fluorescence microscope (Leica DMLB, Leica). In so doing, we
analysed a cortex volume of 5–6 mm3 in each mouse. Mean and
median values of the number of traced neurons were calculated and
compared between wild-type and APP23 mice. Statistical analysis
was performed using the Mann–Whitney U-test to compare
wild-type and APP23 mice. Poisson regression was used to identify
differences among the different phases of Ab-deposition in the
brain. Appropriate corrections for multiple testing were made.
SPSS 11.0 (SPSS, Chicago, IL, USA) and LogXact 5.0 (Cytel Software
Corporation, Cambridge, MA, USA) software were used to calculate
statistical tests.
Immunohistochemistry
Immunohistochemistry was performed for the detection and quan-
tification of Ab-plaques. After formic acid pretreatment free-floating
sections were incubated with an anti-Ab antibody [polyclonal rabbit
(Wild-Bode et al., 1997), 1/750, 24 h at 22C]. The polyclonal anti-
body detected Ab1-40 as well as Ab1-42. To separately detect Ab40 and
Ab42 positive material, additional sections were stained with mono-
clonal antibodies specifically detecting the C-terminus of Ab40
[MBC40 (Yamaguchi et al., 1998), 1/20, 24 h at 22C, formic
acid pretreatment] and Ab42 [MBC42 (Yamaguchi et al., 1998),
1/200, 24 h at 22C, formic acid pretreatment]. The primary anti-
body was detected with a biotinylated secondary antibody and the
ABC complex, and visualized with DAB (Hsu et al., 1981). Sections
were mounted in Corbit (Hecht, Hamburg, Germany).
Quantification of the Ab-plaque load was performed in an area of
the frontocentral neocortex in one selected section with plaques
using a Zeiss Stemi2000C microscope and Axiovision AC 4.2
image analysis software (Carl Zeiss Lichtmikroskopie, Go¨ttingen,
Germany). The Ab-plaque load was measured for plaques stained
with the polyclonal antibody raised against Ab1–42 (Wild-Bode et al.,
1997) according to the following determination:
Mean values of the Ab-plaque load were compared between 3-, 5-,
11- and 15-month-old APP23 mice with ANOVA (analysis of var-
iance).
To characterize the expansion of Ab-deposition in the mouse
brain we determined the phases of Ab-deposition valid for
human and APP-transgenic mouse brain (Thal et al., 2002b;
Wiederhold et al., 2004; Thal et al., 2006) (Table 1).
To identify axonal sprouting and axonal damage, sections of the area
of interest of each mouse were stained with antibodies directed against
APP (22C11, monoclonal mouse, Chemicon (Temecula, CA, USA),
1/75, 24 h at 22C) and against growth-associated protein GAP43 (poly-
clonal rabbit, Chemicon, 1/75, 24 h at 22C) (Masliah et al., 1992a, b).
Results
Subpopulations of commissural neurons in
layer III of the frontocentral cortex
Using retrograde tracing with DiI, three different types of
commissural neurons were identified in layer III of the
frontocentral cortex in wild-type and APP23 mice at the
age of 3, 5, 11 and 15 months (Fig. 2A–F). The first type
of commissural neurons, referred to as type I, showed a
DiI-labelled perikaryon of pyramidal shape, an apical den-
drite and multiple basal dendrites with a heavily ramified and
spiny dendritic tree. Ramification of the dendrites was char-
acterized by branching of apical and basal dendrites into
primary branches exhibiting secondary and tertiary ramifica-
tions within layer III (Fig. 2A and D). The basal dendrites
were restricted to layers II/III. The apical dendrite showed
further ramification within the molecular layer. These type I
commissural neurons were predominantly located in the
upper part of layer III (Fig. 2D). The second type of com-
missural neurons, referred to as type II, exhibited a DiI-
labelled perikaryon of pyramidal shape. The apical and
basal dendrites were detectable, but further ramification
and dendritic spines were less frequently observed and the
basal dendrites were thicker than those of type I commissural
neurons (Fig. 2B, E and F). 3D reconstruction revealed that
the basal dendrites of type II commissural neurons start
branching distant from the perikaryon (Fig. 2F). Commis-
sural neurons of type II showed dendritic ramification and
spines in the molecular layer as detected by following the
apical dendrite in consecutive sections and, thus, represent
the classical pyramidal cell morphology. These neurons were
most frequently located in the lower part of layer III. Branches
of their basal dendrites were also seen in the upper part of
layer IV (Fig. 2E and F). The third type of commis-
sural neurons, referred to as type III, did not exhibit clearly
distinguishable apical and basal dendrites within layer III.
Table 1 Phases of Ab-deposition in APP23 mice brain
Phase 0 Absence of Ab deposits
Phase 1 Ab deposits in the neocortex
Phase 2 Ab deposits in the neocortex and allocortex
Phase 3 Ab deposits in the neocortex, allocortex,
thalamus and striatum
Phase 4 Ab deposits in the neocortex,
allocortex, thalamus, striatum and
midbrain basal ganglia and brainstem
Phase 5 Ab deposits in the neocortex,
allocortex, thalamus, striatum, brain stem
and cerebellum
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Only the cell body with a circular shape was clearly labelled
with the tracer. Single, very thin dendrites without spines were
labelled in layer III (Fig. 2C and F). These neurons did not show
a predilection site in layer III. They occurred in the upper as well
as in the lower parts of this cell layer. In all types of commissural
neurons the axon left the neuron at the base and was part of the
callosal commissural fibre system. In vivo tracing of wild-type
mice with BDA confirmed the staining pattern and the
existence of three different types of commissural neurons
seen in the DiI-traced sections (Fig. 2G–I).
Alteration of commissural neurons in
APP23 mice
At 3 months of age there were no differences between wild-
type and APP23 mice in the morphology of the commissural
Fig. 2 Three types of commissural neurons traced in the frontocentral cortex of wild-type mice. A, B and C show the typical pattern of
these three types of neurons as characterized in 100-mm-thick sections after tracing with DiI. Type I commissural neurons are characterized
as pyramidal shaped neurons with apical (white arrow) and basal (unfilled arrow) dendrites creating a heavily ramified and spiny dendritic
tree showing secondary and tertiary branches within layer III. The axon leaves the perikaryon at the base (unfilled arrowhead; A). These
neurons are mainly located within the upper part of layer III (D). The second type of commissural neurons is the sparsely ramified pyramidal
neuron. These neurons are also characterized by a pyramidal cell body and traced apical (white arrow) and basal (unfilled arrow) dendrites.
These cells represent the classical pyramidal cells in layer III. There is almost no further ramification of the apical and basal dendrite
detectable in this type of neuron within layer III. The basal dendrites start branching distant from the perikaryon as shown in a 3D
reconstruction of serial scans (F). The axon is visible at the base of the perikaryon (unfilled arrowhead; B). These neurons are preferentially
found in the lower part of layer III (E and F). (C) Non-pyramidal commissural neurons, referred to as type III commissural neurons, are
characterized by a circular cell body. A few dendrites arise from the perikaryon (arrowhead). There is no further ramification seen in this
type of neuron. The axon is not seen in this section. Type III commissural neurons do not exhibit a distinct predilection site within layer III (F
and I). (G–I) Tracing with biotinylated dextran confirms the staining pattern of the three types of commissural neurons as seen with DiI
tracing. A–C show DiI-traced neurons in wild-type mice at 11 months of age, D–F in those of 5 months of age. A–C and F represent 3D
stacks of 16 images of cells 1.25–1.75 mm distance recorded with the laser scan confocal microscope; D and E are images digitally captured
with the Leica DMLB-microscope. (G–I) Commissural neurons traced with biotinylated dextran 3 days before death in wild-type mice of 3
months of age mice. Calibration bar in C valid for A: 55 mm, B and C: 40 mm. Calibration bar in F valid for D and E: 35 mm, F: 50 mm.
Calibration bar in I valid for G–I: 35 mm.
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neurons (Fig. 3A and B). In contrast, type I commissural
neurons were morphologically altered in APP23 mice
compared with wild-type mice at 5, 11 and 15 months of
age (Fig. 3C and D). In APP23 mice, the apical dendrite was
shorter than that in wild-type animals (Fig. 3C and D). The
basal dendrites exhibited a non-symmetric pattern and short
secondary or tertiary branches, and their diameter was often
reduced (Fig. 3D). In comparison, in wild-type mice this type
of neurons showed a symmetrical architecture of the basal
dendrites and secondary and tertiary branches were longer
than those in APP23 transgenic mice (Fig. 3C and D). Altered
type I commissural neurons in APP23 mice were often
located distant from Ab-plaques identified by subsequent
immunostaining with anti-Ab1–42 or by Ab-plaque-induced
autofluorescence (Thal et al., 2002a).
There were no apparent differences in the morphological
patterns of type II and type III commissural neurons among
APP23 and wild-type mice.
Selective reduction of type I commissural
neurons in APP23 mice
Quantitative analysis of traced commissural neurons in 5- to
15-month-old wild-type mice showed that type II com-
missural neurons were predominant (60–80%), while type
I (10–20%) and type III neurons (10–20%) were less
abundant. The number of traced type I neurons appeared
to decrease with age, but this trend failed significance (trend
test: P = 0.108) (Fig. 4A). In 3-month-old animals a similar
percentage of type I neurons was found (10–20%) while type
II neurons were less predominant (40–45%). In these animals
the number of type III neurons was higher than that in older
animals (P < 0.01; ANOVA corrected for multiple testing by
using the Tamhane T2 post hoc test) and covered 40–45% of
all traced commissural neurons (Fig. 4C).
The overall number of commissural neurons did not show
significant differences between wild-type and transgenic mice
at a given age (Mann–Whitney U-test, corrected for multiple
testing: 3 months: P = 0.9917; 5 months: P = 0.2126;
11 months: P = 0.9579; 15 months: P = 0.3232). However,
with increasing expansion of Ab-deposition throughout the
brain the total number of neurons decreased (Poisson regres-
sion analysis controlled for age: risk-ratio = 0.967, 95%
confidence interval (CI) = 0.941–0.9938, P < 0.05; trend-
test: P < 0.05).
In detail, the number of traced type I commissural
neurons in APP23 mice was reduced by >90% compared
with that of wild-type mice at 5, 11 and 15 months of age
(Mann–Whitney U-test, corrected for multiple testing:
5 months APP23 versus wild-type: P < 0.05; 11 months
APP23 versus wild-type: P < 0.005; 15 months APP23 versus
wild-type: P < 0.01) but not at 3 months of age (Mann–
Whitney U-test, corrected for multiple testing: 3 months
APP23 versus wild-type: P = 0.9917) (Fig. 4A). With the
expansion of Ab-deposition the number of traced type I
neurons decreased significantly (Poisson regression analysis
controlled for age: risk-ratio = 0.3417, CI = 0.174 – 0.6712,
P < 0.005).
The number of type II commissural neurons did not
show significant differences between wild-type and APP23
mice at 3, 5 and 11 months of age (Mann–Whitney U-test,
corrected for multiple testing: 3 months: P = 1; 5 months:
P = 0.182; 11 months: P = 0.9375) (Fig. 4B). However, at
15 months of age a significant reduction of traced type II
neurons was observed in APP23 mice compared with
wild-type (Mann–Whitney U-test, P-values corrected for
multiple testing: 15 months: P < 0.05). Over all ages the
number of traced type II neurons decreased significantly
with the expansion of Ab-deposition (Poisson regression
analysis controlled for age: risk-ratio = 0.9432, CI =
0.9033–0.9849, P < 0.01).
The number of type III commissural neurons did not
significantly differ among APP23 and wild-type mice, neither
at 3 nor at 5, 11 or 15 months of age (Mann–Whitney
U-test, corrected for multiple testing: APP23 versus
Fig. 3 DiI-traced type I commissural neurons in the frontocentral
cortex of 3- and 5-month-old wild-type and APP23 mice. (A) Type
I commissural neurons in layer III of the frontocentral cortex show
a highly ramified dendritic tree in 3-month-old wild-type mice. The
basal dendrites exhibit secondary and tertiary branches and are
symmetrically organized. (B) In APP23 mice of 3 months of age
there are no significant differences in the architecture of the
dendritic tree when compared with that of wild-type animals.
(C) In 11-month-old wild-type animals the dendritic tree of a type I
commissural neuron shows further ramifications. The dendritic
tree has still a perfect symmetric architecture. (D) Type I
commissural neuron in an 11-month-old APP23 mouse exhibits a
dendritic tree that shows a non-symmetric architecture of the
basal dendrites. A number of basal dendrites are small and
shrunken (arrow) while others still appear in regular size (unfilled
arrowhead). This pattern of type I neurons is strikingly different
from that at 3 months of age and that of wild-type animals at
11 months of age. Calibration bar: 22 mm.
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wild-type: 3 months: P = 0.8651; 5 months: P = 0.9749;
11 months: P = 0.453; 15 months: P = 0.3232) (Fig. 4C).
In addition, there was no significant change in the number
of traced type III neurons throughout the phases of Ab-
deposition (Poisson regression analysis controlled for age:
risk-ratio = 1.0409, P = 0.1533).
Ab-production and Ab-deposition in
APP23 mice
Western blot analysis confirmed overexpression of human
APP and production of Ab1–40 and Ab1–42 in APP23 mice
(Fig. 5). Quantification of total Ab levels by ELISA in APP23
mice at 3, 5, 11 and 15 months of age showed a significant
exponential increase of Ab with the age (Table 2) (ANOVA
corrected for multiple testing by using the Tamhane T2 post
hoc test: Ab1–40 P < 0.001; Ab1–42 P < 0.001). Total Ab1–40
levels, thereby, were higher than total Ab1–42 levels (sign test:
P < 0.001). Between 3 and 5 months of age total Ab levels did
not differ significantly (ANOVA corrected for multiple test-
ing by using the Tamhane T2 post hoc test: Ab1-40 P = 0.786;
Ab1-42 P = 0.963). However, between 5 and 11 months of age
an increase of both Ab1-40 and Ab1-42 was seen (ANOVA
corrected for multiple testing by using the Tamhane T2
post hoc test: Ab1-40 P < 0.05; Ab1-42 P < 0.01), as well as
between 11 and 15 months of age (ANOVA corrected for
multiple testing by using the Tamhane T2 post hoc test:
Ab1-40 P < 0.01; Ab1-42 P < 0.001).
Immunohistochemistry with a polyclonal antibody
detecting Ab1-40 as well as Ab1-42 revealed no Ab-deposits
in wild-type mice at 3, 5, 11 or 15 months. APP23 mice did
not show plaques at 3 months of age. Single plaques in the
frontocentral neocortex were observed in 67% of the APP23
mice at 5 months of age representing Phase 1 of Ab-
deposition (Table 3) (ANOVA corrected for multiple testing
by using the Tamhane T2 post hoc test: P < 0.05). However,
Fig. 4 Diagrams representing mean number and standard deviation of type I, II and III commissural neurons in each strain at 3, 5, 11 and 15
months of age. (A) Type I commissural neurons in wild-type and APP23 mice at 3, 5, 11 and 15 months of age. APP23 mice show a decrease
of >90% of the type I commissural neurons compared with wild-type mice at 5, 11 and 15 months of age. (B) Type II commissural neurons in
wild-type and APP23 mice. There are no significant differences in the number of type II commissural neurons at 3, 5 and 11 months of age
between wild-type and APP23 mice. Only in 15-month-old APP23 mice the number of type II commissural neurons is decreased compared
with wild-type animals. At this age less type II neurons are labelled when compared with younger APP23 mice (Kruskal–Wallis H-test: P <
0.005, trend-test: P < 0.05). (C) Type III commissural neurons in wild-type and APP23 mice. Neither at 3 nor at 5, 11 and 15 months of age
are there significant differences in the number of non-pyramidal commissural neurons between wild-type and APP23 mice. Between 3
months of age and 5–15 months of age there is a reduction of 80% of type III neurons. In mice older than 3 months, type II commissural
neurons are the predominant type of commissural neurons in the frontocentral cortex representing 60–80% of them. Type I and III
commissural neurons are less frequently detectable than type II commissural neurons, and each represent 10–20% of the commissural
neurons. *P < 0.05; **P < 0.01.
Fig. 5 Western blot analysis of APP and Ab in forebrain
homogenates of wild-type and APP23 mice at the ages of 5 and
11 months. flAPP is detected with an antibody directed against
mouse and human APP (APP-C8). Transgenic human APP (hAPP) is
stained with a human-specific Ab antibody that also reacts with
human APP (6E10). In the lowest panel, Ab1–40 and Ab1–42 are
detected with the 6E10 antibody after immunoprecipitation with
the anti-Ab antibody b1 except for the 11-month-old APP23
sample. To compensate for the Ab accumulation, this sample was
diluted and represents 80 times less forebrain tissue than the other
samples. Both Ab1–40 and Ab1–42 are detectable in APP23 mice at
5 and 11 months of age while no significant amounts of Ab are seen
in wild-type mice.
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differences in the Ab-plaque load did not reach significance
between 3- and 5-month-old APP23 mice (ANOVA corrected
for multiple testing by using the Tamhane T2 post hoc test:
P = 0.096) (Fig. 6A). Between 5- and 11-month-old APP23
mice the Ab-plaque load in the frontocentral cortex increased
(ANOVA corrected for multiple testing by using the
Tamhane T2 post hoc test: P < 0.005). Additionally,
11-month-old mice often exhibited an involvement of
allocortical brain regions, that is, the hippocampal formation
and the cingulate gyrus in Ab-deposition representing
Phase 2 of Ab-deposition (Fig. 6B, Table 3) (ANOVA cor-
rected for multiple testing by using the Tamhane T2 post hoc
test: P < 0.005). Between the ages of 11 and 15 months there
was a further increase in the Ab-plaque load within the
frontocentral cortex (ANOVA corrected for multiple testing
by using the Tamhane T2 post hoc test: P < 0.001) (Fig. 6A),
and additional Ab-plaques occurred in the basal ganglia as
well as in the thalamus, indicating Phase 3 of Ab-deposition
(ANOVA corrected for multiple testing by using the
Tamhane T2 post hoc test: P < 0.001) (Fig. 6B, Table 3).
Ab-deposits in APP23 mice exhibited equal staining patterns
with anti-Ab42 and anti-Ab40 antibodies. Ab-deposition
according to the pattern of Phase 4 or Phase 5 has not
been observed in 3-, 5-, 11- and 15-month-old APP23 mice.
Axonal sprouting of commissural neurons
in APP23 mice
Immunohistochemistry with antibodies directed against APP
and GAP43 showed the presence of immunolabelled, thick-
ened axon endings in the frontocentral cortex of 3-month-old
wild-type and APP23 mice indicative for axonal sprouting
(Fig. 7A–D). In the DiI-traced sections we found collateral
sprouting in wild-type and APP23 mice at 3 months of age.
Single axons of commissural neurons with growth cones were
seen in layers II and III of the frontocentral cortex of the DiI-
traced sections (Fig. 7E). In 5-month-old mice thickened
axon endings of commissural neurons in DiI-traced sections
were no longer observed. However, single APP and GAP43-
positive, thickened axon endings were found in APP23 mice
but not in wild-type mice at this age (Fig. 7F–I). Sprouting of
commissural neurons around plaques was observed in 11-
and 15-month-old APP23 mice in DiI-traced sections
(Fig. 7L) as well as in APP and GAP43-stained sections
(Fig. 7J and K). Wild-type mice did not show sprouting of
commissural neurons in this age in DiI-traced sections.
Only single APP and GAP43-positive sprouting axons
were detected in the frontocentral cortex of 15-month-old
wild-type mice.
Discussion
In this study, we show that three types of commissural
neurons in layer III of the mouse frontocentral cortex can
be identified using tracing methods. These different neuron
types are hierarchically affected by Ab-induced neurodegen-
eration. The deposition of the first Ab-plaques is associated
with the onset of neurodegeneration in APP23 mice. Expan-
sion of Ab-deposition into further brain regions goes along
with the involvement of a second type of commissural neu-
rons in neurodegeneration. The complexity of the dendritic
morphology is, thereby, related to the vulnerability of these
different types of neurons.
Characterization of three types of
commissural neurons in the mouse
frontocentral neocortex
Our study confirms and extends previous reports that
describe different types of pyramidal and non-pyramidal neu-
rons projecting through the corpus callosum (Hughes and
Peters, 1992; Martinez-Garcia et al., 1994). The distinction of
the three types of commissural neurons in the mouse fron-
tocentral cortex is based on their morphological appearance
after retrograde tracing with DiI. It is confirmed by using
biotinylated dextran in vivo tracing as an additional method.
Type I commissural neurons are characterized by a pyr-
amidally shaped perikaryon and apical and basal dendrites
with a heavily ramified and spiny dendritic tree within layer
II–III. Type II commissural neurons represent neurons with a
pyramidally shaped perikaryon and apical and basal den-
drites, which do not show extensive further ramifications
in layer III in a given tissue section. However, 3D reconstruc-
tion revealed that the basal dendrites of these neurons start
branching distant from the perikaryon. Type III commissural
Table 2 Mean levels of Ab1–40 and Ab1–42 concentration in the forebrain of APP23 mice determined by ELISA
Age (months) Ab140 (pmol/g) SD Ab142 (pmol/g) SD
3 22.51 63.16 2.25 60.36
5 25.94 65.60 } P < 0.05 2.46 60.40 } P < 0.0111 5447.09 61437.67 1668.36 6256.46
15 28919.74 67699.72 } P < 0.01 6019.74 61146.88 } P < 0.001
Table 3 Percentage of mice exhibiting Ab-deposits
in a given phase at a given age. Animals at 15 months of
age did not show higher phases than Phase 3.
Age (months) Phase 0 Phase 1 Phase 2 Phase 3
3 100.0% 0.0% 0.0% 0.0%
5 33.3% 66.7% 0.0% 0.0%
11 0.0% 33.3% 66.7% 0.0%
15 0.0% 0.0% 11.1% 88.9%
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neurons are non-pyramidal neurons and have a circular cell
body with a few dendrites.
In contrast to the other types of commissural neurons, type
III neurons are reduced in number in 5-, 11- and 15-month-
old animals in comparison with 3-month-old mice regardless
of the genotype. Thus, an effect of Ab or APP-overexpression
is not responsible for the reduction of type III neurons
because wild-type mice show the same effects as APP23
mice. To explain this finding, further studies are required.
Developmental or maturation-related phenomena (Fritzsch
et al., 1997) might be involved.
All three types of neurons were found in all mice studied,
and their axons projected through the corpus callosum to the
contralateral hemisphere. Since tracer-labelled type I, II and
III commissural neurons were visible in the same section close
to one another and type II neurons showed dendritic rami-
fication in the molecular layer, it seems unlikely that DiI
tracing of neurons without a ramified dendritic tree is due
to dysfunctional tracing rather than to the exhibition of spe-
cific morphological types of neurons. Galuske and Singer
(1996) also reported that in the event that a given cell is
stained by DiI all cell processes will be labelled. Moreover,
a second tracing method based on in vivo transport of the
biotinylated dextrane (Reiner et al., 2000) confirmed the
presence of three different types of commissural neurons.
The heterogeneous morphological pattern of commissural
neurons in the frontocentral cortex of mice confirms and
extends the finding of other authors that the visual cortex
contains different types of callosal commissural neurons
(Voigt et al., 1988; Buhl and Singer, 1989; Martinez-Garcia
et al., 1994). They also reported the presence of commissural
neurons of pyramidal and non-pyramidal types. Cortical
commissural neurons project to different layers of the con-
tralateral hemisphere (Wise and Jones, 1976; Martinez-Garcia
et al., 1994). In so doing, the different types of frontocentral
commissural neurons may terminate in different layers of the
contralateral hemisphere and may have specific functions in
commissural information processing.
Degeneration of distinct types of
commissural neurons in APP23 mice
Two of the three types of commissural neurons were reduced
in number when traced in APP23 transgenic mice. Type I
commissural neurons were significantly reduced in number
in APP23 mice beginning at 5 months of age. The surviving
type I commissural neurons in these mice exhibited altera-
tions of the dendritic tree in comparison with wild-type ani-
mals. The other types of commissural neurons did not show
obvious differences between transgenic and wild-type mouse
lines at this point in time. The second type of neurons, type II
commissural neurons, was reduced in number at 15 months
of age. Thus, the number of traced commissural neurons
apparently decreases in APP23-transgenic mice as soon as
they start developing Ab-deposits at 5 months of age.
With increasing age, Ab-plaque load and Ab-expansion, a
second type of neuron becomes involved in Ab-induced neu-
rodegeneration. However, type III commissural neurons were
not altered. The degeneration of type I and II commissural
neurons in APP23 mice can be interpreted (i) as a result of
selective neuronal death; (ii) as the result of dendritic altera-
tions; or (iii) as a consequence of axonal damage. The first
possibility of selective neuronal death is supported by the
decrease of the total number of neurons in the hippocampus
Fig. 6 (A) Quantification of the Ab-plaque load in the frontocentral cortex of APP23 mice. (A) There is no significant difference in the
Ab-plaque load between 3- and 5-month-old animals. The single plaques seen in 5-month-old animals did not lead to a significant increase
in the Ab-plaques load (P = 0.096). Between 5 and 11 as well as between 11 and 15 months the Ab-plaque load increases. (B) Distribution
of Ab-plaques as described by the phases of Ab-deposition (Thal et al., 2002b) in APP23 mice. Three-month-old animals do not show
plaques. Ab-deposition starts with the first plaques in 5-month-old APP23 mice. Sixty-seven per cent of these mice exhibited Ab-plaques
in a distribution pattern related to Phase 1. A significant expansion of Ab-deposition as represented by an increasing phase is seen with
advancing age. Boxes represent mean values. Bars indicate the standard deviation. *P < 0.05; **P < 0.01; ***P < 0.001.
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of APP-transgenic mice, indicating that neuronal loss can
result from abnormal production of Ab (Calhoun et al.,
1998; Schmitz et al., 2004). A second supporting argument
is that in Down syndrome patients overexpressing APP (Neve
et al., 1988) neuronal loss is accentuated in layer III of the
frontocentral cortex (Davidoff, 1928). On the other hand, the
second possibility that the reduction of heavily ramified type I
commissural neurons is due to dendritic changes is supported
by a recent finding indicating that dendritic length is reduced
in a specific group of dentate granule cells in PDAPP trans-
genic mice (Wu et al., 2004). Together with our finding of an
asymmetrically ramified dendritic tree in altered type I com-
missural neurons it is likely that dendritic alterations would at
least precede neuronal death. In so doing, it is possible that
degenerated type I and II neurons may appear morphologi-
cally as type II or III commissural neurons, respectively. The
third hypothesis for the reduction of the number of traced
commissural neurons is a loss of axonal connectivity between
the hemispheres. This hypothesis is supported by axonal
sprouting seen in aged APP-transgenic mice (Phinney et al.,
1999; Teter and Ashford, 2002) indicating regeneration after
axonal injury (Deller and Jucker, 2001) and by the degenera-
tion of myelinated axons (Bartzokis et al., 2003), especially in
the corpus callosum of human Alzheimer’s disease cases
(Weis et al., 1991; Yamauchi et al., 1993; Hampel et al.,
1998). However, our tracing study as well as that of
Phinney et al. (1999) did not exhibit collateral sprouting
of commissural neurons in 5-month-old APP23 mice already
exhibiting a decrease in the number of traced type I com-
missural neurons. Abnormal axonal sprouting of commis-
sural neurons in APP23 mice starts at 11 months of age
and, therefore, axonal damage may not be the first step in
the degeneration of these neurons.
Single APP and GAP-43 positive neurites occur in the
frontocentral cortex of APP23 mice at 5 months, indicative
for axonal sprouting (Masliah et al., 1992a, b). Since com-
missural neurons do not show sprouting at this age, these
APP and GAP-43 positive neurites represent sprouting axon
terminals from non-commissural neurons. Such a sprouting
is not seen in wild-type littermates. Ab-aggregates alone do
not explain this selective sprouting. If Ab-aggregates alone
would induce such a sprouting, one would expect a contri-
bution of neurites from all types of afferent neurons including
commissural neurons. Therefore, it is tempting to speculate
that these sprouting neurites in 5-month-old APP23 mice
represent reactive sprouting following the degeneration of
type I commissural neurons.
Taken together, dendritic and axonal degeneration as well
as neuronal death may be involved in the degeneration of type
Fig. 7 Sprouting and degenerating axons in the frontocentral
cortex of wild-type (wt) and APP23 mice. (A–E) APP and
GAP43-positive thickened axonal endings in the frontocentral
neocortex of wild-type and APP23 mice at 3 months of age. APP
positive axonal endings (arrow in B) are found in layer III of the
frontocentral cortex (A, B representing the enlargement of the
boxed area in A). The axonal endings occur in wild-type as well as
in APP23 mice and appear as thickened growth cones of sprouting
axons (arrows in B and C) also exhibiting GAP43 (arrow in D). DiI
tracing also shows swollen axon endings (arrows) in layer III of the
contralateral hemisphere indicating an involvement of commissural
neurons in these changes (E). (F–I) At 5 months of age wild-type
mice do not show APP or GAP43-positive sprouting or
degenerating axons (F). In contrast, APP23 mice exhibit single
APP-positive, thickened axonal endings (arrows in H–I; H
represents the enlargement of the boxed area in G). (J–L) At 11
and 15 months of age APP-positive dystrophic neurites are seen in
association with plaques (arrows in K representing the
enlargement of the boxed area in J). Some of these neurites were
identified as aberrant sprouting axons (arrows) arising from
commissural neurons by DiI tracing around amyloid plaques in the
contralateral frontocentral cortex (L). The amyloid nature of the
plaque is demonstrated by the exhibition of the Ab-plaque-specific
blue autofluorescence under UV-light excitation (Thal et al.,
2002a). Calibration bar: A, F, G and J = 300 mm, B–E, H and
I = 20 mm, K = 40 mm, L = 70 mm.
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I and II commissural neurons in a distinct sequence. In a first
step dendritic processes of the nerve cells may degenerate
presumably followed by axonal damage and, finally, nerve
cell death. This sequence is similar to that seen in human
Alzheimer’s disease for neurons accumulating NFTs
(Bancher et al., 1989; Braak et al., 1994; Thal et al.,
2000a). Here, neurodegeneration starts with dendritic and
perikaryal accumulation of abnormal t-protein, followed
by the creation of NFTs, axonal accumulation of abnormal
t-protein in the target region of affected neurons and,
finally, neuronal death (Braak et al., 1994; Sassin et al.,
2000; Thal et al., 2000a).
The relationship between
neurodegeneration and Ab-pathology
The loss of traceable type I commissural neurons in 5-month-
old APP23 mice is associated with the deposition of the first
Ab-plaques within the frontal cortex of these animals. How-
ever, total Ab-levels as well as the Ab-plaque load do not differ
significantly between 3- and 5-month-old APP23 mice, and
there is no close spatial relationship between Ab-plaques and
degenerating commissural neurons in 5-month-old APP23
mice. These results indicate that Ab-induced degeneration
of neurons in the brain is not due to a simple increase in
Ab-levels or to Ab-plaques themselves but due to qualitative
changes in the status of Ab-aggregation. Our results support
other studies showing that the aggregation of Ab to soluble
Ab-oligomers and/or fibrils is required for Ab-toxicity
(Podlisny et al., 1995; Kayed et al., 2003; Kim et al., 2003;
Cleary et al., 2005) and go beyond the findings of other authors
that Ab-plaques induce local dendritic or neuritic degenera-
tion (Tsai et al., 2004; Brendza et al., 2005; Spires et al., 2005).
Our finding of a hierarchical involvement of different types
of neurons in Ab-induced neurodegeneration further extends
the present knowledge of Ab-toxicity and argues in favour of
a selective vulnerability of neurons to Ab. Since we have
studied only commissural neurons projecting into the same
area of the contralateral cortex, all neurons have the same
axon lengths and all neurons function as commissural
neurons. Axon lengths and the function of the neuron do,
therefore, not appear to be responsible for the selective
vulnerability of distinct types of neurons. All pyramidal
neurons use excitatory amino acids (glutamate or aspartate)
as transmitter (Conti et al., 1988; Giuffrida and Rustioni,
1989). Thus, at least type I and II commissural neurons
share a similar neurotransmitter but differ in their vulnerabil-
ity. Therefore, the selective vulnerability of commissural neu-
rons is most likely not due to the neurotransmitter of the
different types of commissural neurons examined in this study.
The most significant difference between type I, II and III
commissural neurons is the morphology of the dendritic tree
(Fig. 8). Type I neurons exhibit a highly ramified dendritic tree
with basal dendrites branching exclusively in layer III, whereas
type II neurons have a less ramified dendritic tree with den-
drites also branching into layer IV. The type III neurons, in
contrast, show only single dendrites without significant
further ramification into secondary and tertiary dendrites.
Thus, it is tempting to speculate that neurons with a highly
ramified dendritic tree present a better target for toxic changes
by oligomeric and/or fibrillar Ab than neurons with a less
ramified dendritic tree. This hypothesis is supported (i) by
the finding of Roselli et al. (2005) that soluble Ab-oligomers
induce N-methyl-D-aspartate (NMDA) dependent degrada-
tion of post-synaptic density-95 at glutamatergic synapses
on dendrites; (ii) by the Ab-induced inhibition of long-
term potentiation (Wang et al., 2002); and (iii) by the loss
of dendritic spines seen in the vicinity of amyloid plaques
(Tsai et al., 2004; Spires et al., 2005). Our finding that Ab-
induced neurotoxicity induces dendritic alterations of type I
commissural neurons also argues in favour of the dendritic
tree to be the primary target of Ab-toxicity. The primary
deposition of Ab in the neocortical layers III and V (Braak
and Braak, 1991; Price et al., 1991; Arriagada et al., 1992; Thal
et al., 2000b) may support this hypothesis insofar as neurons
with a dendritic tree branching exclusively within layer III and
the molecular layer are target of Ab-induced neurodegenera-
tion at an earlier time point compared with neurons with basal
dendrites escaping layer III-Ab by branching into layer IV.
Our results in concert with that of other authors (Wang
et al., 2002; Roselli et al., 2005) support the hypothesis that
oligomeric and/or fibrillar Ab-aggregates interact with den-
drites and that neurons may degenerate when their dendrites
are exposed to Ab-aggregates. The size of the target for Ab,
that is, the dendritic tree surface in a given area, presumably
contributes to the vulnerability of neurons to Ab. The
primary involvement of dendrites in Ab-toxicity has been
demonstrated in dentate gyrus neurons as well (Wu et al.,
2004). The interaction of Ab-oligomeric diffusible ligands
(ADDLs) with the dendrites (Lacor et al., 2004) could explain
whyWu et al. (2004) did not detect any Ab-deposits although
they found dendritic degeneration and it could also explain
why 33% of the 5-month-old APP23 mice in our study did
show neurodegeneration in the absence of Ab-deposits.
Moreover, it is highly unlikely that the principal function
of a neuron (e.g. the function as a commissural neuron),
the length of its axon and the neurotransmitter used are
the only factors determining selective vulnerability against
Ab. Our results show that theories of selective vulnerability
in Alzheimer’s disease based upon the principal function
and axon length of neurons (Braak et al., 2000) need to be
supplemented by other factors to explain Ab-induced
selective vulnerability. The morphology of the dendritic
arbor presumably contributes to this selective vulnerability
of neurons against Ab as demonstrated here.
The impact of Ab-induced
progressive neurodegeneration in
Alzheimer’s disease
In this study we demonstrate that Ab alters different types of
neurons in a distinct hierarchical sequence in an animal
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model for Ab-pathology. After onset of degeneration of a
distinct type of neurons a further type of neurons became
involved with increasing Ab-pathology. Other studies show-
ing degeneration of different types of neurons in animal
models for Alzheimer’s disease used double or triple
transgenic mice (Lewis et al., 2001; Oddo et al., 2003;
Schmitz et al., 2004). In these animals neurodegeneration
cannot be addressed exclusively to Ab because presenilin 1
(Oddo et al., 2003; Schmitz et al., 2004) and/or mutant
t-protein (Lewis et al., 2001; Oddo et al., 2003) are co-
expressed. In contrast, single APP-transgenic mice used in
this study allow the conclusion that Ab alone is capable of
inducing progressive neurodegeneration. Since humans show
a hierarchical sequence in which different types of neurons
develop Alzheimer’s disease-related NFTs and neuronal
loss (Braak and Braak, 1991) that parallels the step-by-step
expansion of Ab-deposits into further brain regions
(Thal et al., 2002b) similar to neurodegeneration and
Ab-deposition in mice, our present results suggest that Ab
is capable of inducing progressive neurodegeneration in
Alzheimer’s disease. Therefore, our results support Ab to
be a major therapeutic target for treatment of Ab-induced
neurodegeneration preferentially in pre-clinical sages. How-
ever, since Ab supports progression of neurodegeneration,
Ab-lowering treatment strategies may also be helpful in later
stages to stop the disease progression.
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Fig. 8 Neurodegeneration in APP23 mice begins when Ab-aggregates can be detected as plaques for the first time at 5 months of age.
Degeneration of neurons is represented in the figure by changing the colour of the neurons to grey. The Ab-level in the brain is not
responsible for neurodegeneration because 3- and 5-month-old APP23 mice have similar Ab-levels but only mice at 5 months of age
show neurodegeneration. There is selective vulnerability to Ab-induced neurodegeneration of distinct types of commissural neurons.
The type I commissural neurons (red) are most vulnerable to Ab, whereas type III neurons (orange) are not vulnerable and type II
neurons (green) are significantly less vulnerable than type I neurons. The selective vulnerability to Ab is related to the anatomy
of the dendritic tree. Those neurons with the most ramified dendritic tree (type I commissural neurons marked in red) degenerate
first. Those neurons with an almost negligible dendritic tree (type III commissural neurons marked in orange) do not degenerate while
neurons with a moderately ramified dendritic tree (type II commissural neurons marked in green) degenerate when high levels of
Ab are present in the brain.
Ab-induced degeneration of commissural neurons Brain (2006), 129, 2992–3005 3003
References
Alzheimer A. Ueber eine eigenartige Erkrankung der Hirnrinde. Allg Zschr
Psych 1907; 64: 146–8.
Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type
pathologic changes in nondemented elderly individuals matches the
pattern in Alzheimer’s disease. Neurology 1992; 42: 1681–8.
Bancher C, Brunner C, LassmannH, BudkaH, Jellinger K, Seitelberger F, et al.
Tau and ubiquitin immunoreactivity at different stages of formation
of Alzheimer neurofibrillary tangles. Prog Clin Biol Res 1989; 317:
837–48.
Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH,
Mintz J. White matter structural integrity in healthy aging adults and
patients with Alzheimer disease: a magnetic resonance imaging study. Arch
Neurol 2003; 60: 393–8.
Bertram L, Tanzi R. Genetics of Alzheimer’s disease. In: Dickson D, editor.
Neurodegeneration: the molecular pathology of dementia. Basel: ISN
Neuropath Press; 2003. p. 40–6.
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes.
Acta Neuropathol 1991; 82: 239–59.
Braak E, BraakH,Mandelkow EM. A sequence of cytoskeleton changes related
to the formation of neurofibrillary tangles and neuropil threads. Acta
Neuropathol 1994; 87: 554–67.
Braak H, Del Tredici K, Schultz C, Braak E. Vulnerability of select neuronal
types to Alzheimer’s disease. Ann N Y Acad Sci 2000; 924: 53–61.
Brendza RP, Bacskai BJ, Cirrito JR, Simmons KA, Skoch JM, Klunk WE, et al.
Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-
associated neuritic dystrophy in PDAPP transgenicmice. J Clin Invest 2005;
115: 428–33.
Buhl EH, SingerW. The callosal projection in cat visual cortex as revealed by a
combination of retrograde tracing and intracellular injection. Exp Brain
Res 1989; 75: 470–6.
Calhoun ME, Wiederhold KH, Abramowski D, Phinney AL, Probst A,
Sturchler-Pierrat C, et al. Neuron loss in APP transgenicmice. Nature 1998;
395: 755–6.
Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ,
et al. Natural oligomers of the amyloid-beta protein specifically disrupt
cognitive function. Nat Neurosci 2005; 8: 79–84.
Conti F, Fabri M, Manzoni T. Glutamate-positive corticocortical neurons in
the somatic sensory areas I and II of cats. J Neurosci 1988; 8: 2948–60.
Davidoff LM. The brain in Mongolian idiocy: report of 10 cases. Arch Neurol
Psychiatry 1928; 20: 1229–57.
DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in
Alzheimer’s disease: correlation with cognitive severity. Ann Neurol
1990; 27: 457–64.
Deller T, Jucker M. Axonsrossung im Zentralnervensystem nach einer La¨sion.
Neuroforum 2001: 11–20.
Dickson DW. The pathogenesis of senile plaques. J Neuropathol Exp Neurol
1997; 56: 321–39.
Duyckaerts C, Dickson DW. Neuropathology of Alzheimer’s disease. In:
Dickson D, editor. Neurodegeneration: the molecular pathology of
dementia and movement disorders. Basel: ISN Neuropath Press; 2003.
p. 47–65.
Esiri MM, Hyman BT, Beyreuther K, Masters CL. Ageing and dementia. In:
Graham DI, Lantos PL, editors. Greenfield’s neuropathology. 6th edn.
Vol. 2. London: Arnold; 1997. p. 153–233.
Fritzsch B, Farinas I, Reichardt LF. Lack of neurotrophin 3 causes losses of
both classes of spiral ganglion neurons in the cochlea in a region-specific
fashion. J Neurosci 1997; 17: 6213–25.
Galuske RA, Singer W. The origin and topography of long-range intrinsic
projections in cat visual cortex: a developmental study. Cereb Cortex 1996;
6: 417–30.
Galuske RA, Schlote W, Bratzke H, Singer W. Interhemispheric asymmetries
of the modular structure in human temporal cortex. Science 2000;
289: 1946–9.
Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C,
et al. Alzheimer-type neuropathology in transgenic mice overexpressing
V717F beta-amyloid precursor protein. Nature 1995; 373: 523–7.
Giuffrida R, Rustioni A. Glutamate and aspartate immunoreactivity in
cortico-cortical neurons of the sensorimotor cortex of rats. Exp Brain Res
1989; 74: 41–6.
Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D,
Schapiro MB, et al. Corpus callosum atrophy is a possible indicator of
region- and cell type-specific neuronal degeneration in Alzheimer
disease: a magnetic resonance imaging analysis. Arch Neurol 1998;
55: 193–8.
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al.
Correlative memory deficits, Abeta elevation, and amyloid plaques in
transgenic mice. Science 1996; 274: 99–102.
Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC)
in immunoperoxidase techniques: a comparison between ABC and
unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;
29: 577–80.
Hughes CM, Peters A. Types of callosally projecting nonpyramidal neurons in
rat visual cortex identified by lysosomal HRP retrograde labeling. Anat
Embryol (Berl) 1992; 186: 183–93.
Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH,
et al. The precursor of Alzheimer’s disease amyloid A4 protein resembles a
cell-surface receptor. Nature 1987; 325: 733–6.
Kayed R, Head E, Thompson JL, McIntire TM,Milton SC, Cotman CW, et al.
Common structure of soluble amyloid oligomers implies common
mechanism of pathogenesis. Science 2003; 300: 486–9.
Kim HJ, Chae SC, Lee DK, Chromy B, Lee SC, Park YC, et al. Selective
neuronal degeneration induced by soluble oligomeric amyloid beta protein.
FASEB J 2003; 17: 118–20.
Klafki HW, Wiltfang J, Staufenbiel M. Electrophoretic separation of betaA4
peptides (1-40) and (1-42). Anal Biochem 1996; 237: 24–9.
Lacor PN, Buniel MC, Chang I, Fernandez SJ, Gong Y, Viola KL, et al.
Synaptic targeting by Alzheimer’s-related amyloid beta oligomers.
J Neurosci. 2004; 24: 10191–200.
Lewis J, Dickson DW, LinWL, Chisholm L, Corral A, Jones G, et al. Enhanced
neurofibrillary degeneration in transgenic mice expressing mutant tau and
APP. Science 2001; 293: 1487–91.
Martinez-Garcia F, Gonzalez-Hernandez T, Martinez-Millan L. Pyramidal
and nonpyramidal callosal cells in the striate cortex of the adult rat. J Comp
Neurol 1994; 350: 439–51.
Masliah E, Mallory M, Ge N, Saitoh T. Amyloid precursor protein is
localized in growing neurites of neonatal rat brain. Brain Res 1992a;
593: 323–8.
Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R, et al.
Localization of amyloid precursor protein in GAP43-immunoreactive
aberrant sprouting neurites in Alzheimer’s disease. Brain Res 1992b;
574: 312–6.
Masliah E,MalloryM,Hansen L, DeTeresa R, AlfordM, Terry R. Synaptic and
neuritic alterations during the progression of Alzheimer’s disease. Neurosci
Lett 1994; 174: 67–72.
Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D. Comparison of
neurodegenerative pathology in transgenic mice overexpressing V717F
beta-amyloid precursor protein and Alzheimer’s disease. J Neurosci 1996;
16: 5795–811.
Masters CL, Multhaup G, Simms G, Pottgiesser J, Martins RN, Beyreuther K.
Neuronal origin of a cerebral amyloid: neurofibrillary tangles of
Alzheimer’s disease contain the same protein as the amyloid of plaque
cores and blood vessels. EMBO J 1985; 4: 2757–63.
Neve RL, Finch EA, Dawes LR. Expression of the Alzheimer amyloid
precursor gene transcripts in the human brain. Neuron 1988; 1:
669–77.
Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al.
Triple-transgenic model of Alzheimer’s disease with plaques and
tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003;
39: 409–21.
Phinney AL, Deller T, Stalder M, Calhoun ME, Frotscher M, Sommer B, et al.
Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal
formation in amyloid precursor protein transgenic mice. J Neurosci 1999;
19: 8552–9.
3004 Brain (2006), 129, 2992–3005 E. Capetillo-Zarate et al.
Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB,
et al. Aggregation of secreted amyloid beta-protein into sodium
dodecyl sulfate-stable oligomers in cell culture. J Biol Chem 1995;
270: 9564–70.
Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques
and related immunohistochemical markers in healthy aging and
Alzheimer’s disease. Neurobiol Aging 1991; 12: 295–312.
Reiner A, Veenman CL, Medina L, Jiao Y, Del Mar N, Honig MG. Pathway
tracing using biotinylated dextran amines. J Neurosci Methods 2000;
103: 23–37.
Roselli F, Tirard M, Lu J, Hutzler P, Lamberti P, Livrea P, et al. Soluble
beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic
density-95 at glutamatergic synapses. J Neurosci 2005; 25: 11061–70.
Sassin I, Schultz C, Thal DR, Rub U, Arai K, Braak E, et al. Evolution of
Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of
Meynert. Acta Neuropathol (Berl) 2000; 100: 259–69.
Schmitz C, Rutten BP, Pielen A, Schafer S, Wirths O, Tremp G, et al.
Hippocampal neuron loss exceeds amyloid plaque load in a
transgenic mouse model of Alzheimer’s disease. Am J Pathol 2004;
164: 1495–502.
Schrader-Fischer G, Paganetti PA. Effect of alkalizing agents on the processing
of the beta-amyloid precursor protein. Brain Res 1996; 716: 91–100.
Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT,
et al. Dendritic spine abnormalities in amyloid precursor protein transgenic
mice demonstrated by gene transfer and intravital multiphoton micro-
scopy. J Neurosci 2005; 25: 7278–87.
Staufenbiel M, Paganetti PA. Electrophoretic separation and
immunoblotting of Ab1-40 and Ab1-42. In: Methods in molecular
medicine: Alzheimer’s disease:methods and protocols. Vol. 32. Totowa, NJ:
Humana Press, 1999; p. 91–99.
Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C,
Rothacher S, et al. Two amyloid precursor protein transgenic mouse
models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA
1997; 94: 13287–92.
Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P,
Van Keuren ML, et al. Amyloid beta protein gene: cDNA, mRNA
distribution, and genetic linkage near the Alzheimer locus. Science 1987;
235: 880–4.
Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS. Some
morphometric aspects of the brain in senile dementia of the Alzheimer
type. Ann Neurol 1981; 10: 184–92.
Teter B, Ashford JW. Neuroplasticity in Alzheimer’s disease. J Neurosci Res
2002; 70: 402–37.
Thal DR, Holzer M, Ru¨b U, Waldmann G, Gunzel S, Zedlick D, et al.
Alzheimer-related tau-pathology in the perforant path target zone and in
the hippocampal stratum oriens and radiatum correlates with onset and
degree of dementia. Exp Neurol 2000a; 163: 98–110.
Thal DR, Ru¨b U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, et al.
Sequence of Abeta-protein deposition in the human medial temporal lobe.
J Neuropathol Exp Neurol 2000b; 59: 733–48.
Thal DR, Ghebremedhin E, Haass C, Schultz C. UV light-induced
autofluorescence of full-length Abeta-protein deposits in the human
brain. Clin Neuropathol 2002a; 21: 35–40.
Thal DR, Ru¨b U, Orantes M, Braak H. Phases of Abeta-deposition in the
human brain and its relevance for the development of AD. Neurology
2002b; 58: 1791–1800.
Thal DR, Capetillo-Zarate E, Del Tredici K, Braak H. The development of
amyloid b-protein (Ab)-deposits in the aged brain. Sci Aging Knowl
Environ 2006; 6, re1.
Tsai J, Grutzendler J, Duff K, Gan WB. Fibrillar amyloid deposition leads to
local synaptic abnormalities and breakage of neuronal branches. Nat
Neurosci 2004; 7: 1181–3.
Voigt T, LeVay S, Stamnes MA. Morphological and immunocytochemical
observations on the visual callosal projections in the cat. J Comp Neurol
1988; 272: 450–60.
Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, et al.
Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation
but not long-term depression in rat dentate gyrus. Brain Res 2002;
924: 133–40.
Weis S, Jellinger K, Wenger E. Morphometry of the corpus callosum in
normal aging and Alzheimer’s disease. J Neural Transm Suppl 1991;
33: 35–8.
Wiederhold K-H, Staufenbiel M, Mistl C, Danner S. Stages of
amyloid deposition and plaque types in different APP transgenic mice
as compared to AD [abstract]. Neurobiol Aging 2004; 25 (Suppl. 2): 254–5.
Wild-Bode C, Yamazaki T, Capell A, Leimer U, Steiner H, Ihara Y,
et al. Intracellular generation and accumulation of amyloid beta-
peptide terminating at amino acid 42. J Biol Chem 1997; 272:
16085–8.
Wise SP, Jones EG. The organization and postnatal development of the
commissural projection of the rat somatic sensory cortex. J Comp Neurol
1976; 168: 313–43.
Wu CC, Chawla F, Games D, Rydel RE, Freedman S, Schenk D, et al. Selective
vulnerability of dentate granule cells prior to amyloid deposition in PDAPP
mice: digital morphometric analyses. Proc Natl Acad Sci USA 2004;
101: 7141–6.
Yamauchi H, Fukuyama H, Harada K, Nabatame H, OgawaM, Ouchi Y, et al.
Callosal atrophy parallels decreased cortical oxygen metabolism and
neuropsychological impairment in Alzheimer’s disease. Arch Neurol 1993;
50: 1070–4.
Yamaguchi H, Sugihara S, Ogawa A, Saido TC, Ihara Y. Diffuse plaques
associated with astroglial amyloid beta protein, possibly showing a
disappearing stage of senile plaques. Acta Neuropathol (Berl) 1998;
95: 217–22.
Ab-induced degeneration of commissural neurons Brain (2006), 129, 2992–3005 3005
